Skip to content
Screener

Playtika Holding Corp. PLTK Payment Of Excess Acquisition Date Fair Value Of Contingent Consideration

Payment Of Excess Acquisition Date Fair Value Of Contingent Consideration at other companies

Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$4.29M
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$0-100%
Repligen logo
RepligenRGEN
$0-100%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$4.29M
ConocoPhillips logo
ConocoPhillipsCOP
$0
CBIZ logo
CBIZCBZ
$6.3M-78.7%

Other financials

Income statement

See full
Revenue$731.1M+5.0%
Gross profit$538.2M+7.6%
Operating income$134.6M+22.7%
Net income$68.5M+51.9%
EPS (diluted)$0.13+44.4%

Balance sheet

See full
Cash & equivalents$438.5M-12.5%
Total debt$2.5B-0.6%
Total equity-$399.9M-355%
Total assets$3.3B-9.5%

Cash flow

See full
Operating cash flow$28.7M-80.4%
CapEx$8.4M+75.0%
Free cash flow$20.3M-85.6%

Valuation

See full
Market cap$1.25B-23.3%
Enterprise value$3.32B-9.1%
P/S0.4×-0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Operating margin-3.4%-15.8pp
Net margin-8.8%-14.8pp
FCF margin14.8%-1.7pp

Returns & leverage

See full
Return on equity86.9%
Debt / equity-6.3×
Current ratio1.1×-0.2×

Where this comes from

Reported directly by Playtika Holding Corp. in its filing.

Tagged under the XBRL concept playtika:PaymentOfExcessAcquisitionDateFairValueOfContingentConsideration.

The source filing: Playtika Holding Corp.’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 8:36 AM EST
Fiscal year
FY2025
Accession
0001828016-26-000010
Line itemYear ended December 31, 2025Year ended December 31, 2024Year ended December 31, 2023
Change in contingent consideration398.6(9.8)1.4
Loss (gain) from foreign currency7.01.1(2.8)
Non-cash lease expenses (benefit), net10.6(1.4)3.5
Payment of excess acquisition date fair value of contingent consideration(7.9)
Other operating activities(0.4)
Changes in operating assets and liabilities:
Accounts receivable28.610.1(25.6)
Prepaid expenses and other current and non-current assets87.010.3(35.0)

Item 8. Financial Statements and Supplementary Data

FAQ

What is Playtika Holding Corp.'s payment of excess acquisition date fair value of contingent consideration?
Playtika Holding Corp. (PLTK) reported payment of excess acquisition date fair value of contingent consideration of $1.98M in Q4 2025.
What does payment of excess acquisition date fair value of contingent consideration mean?
Payment Of Excess Acquisition Date Fair Value Of Contingent Consideration as reported by Playtika Holding Corp. Common Stock.

Ask your AI about Playtika Holding Corp.'s payment of excess acquisition date fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude